世界におけるRNA干渉(RNAi)治療市場動向2018...市場調査レポートについてご紹介

【英文タイトル】Global RNA Interference (RNAi) Therapy Market Outlook 2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Introduction to RNA Interference (RNAi) Therapy
1.1 Need for RNAi Therapy
1.2 RNAi Technologies

2. Benefits of RNA Interference (RNAi) Therapy

3. RNA Interference (RNAi) Drug Delivery Mechanics
3.1 Role of RNAi in Target Validation
3.2 Role of RNAi in Target Identification

4. Global RNA Interference (RNAi) Therapy Market Overview
4.1 Regional Markets
4.2 Ongoing RNAi Therapy Clinical Trial

5. Global RNA Interference (RNAi) Market Dynamics
5.1 Favorable Market Drivers
5.2 Challenges to be Addressed
5.3 Future Growth Opportunities

6. RNAi Clinical Pipeline by Phase, Indication & Country
6.1 Unknown Phase
6.2 Research
6.3 Preclinical
6.4 Phase-I
6.5 Phase I/II
6.6 Phase-II
6.7 Phase-III

7. Suspended & Discontinued RNAi Profiles
7.1 No Development Reported
7.2 Discontinued
7.3 Suspended

8. Competitive Landscape
8.1 Arrowhead Research
8.2 Alnylam Pharmaceuticals
8.3 Benitec Biopharma
8.4 Dicerna Pharmaceuticals
8.5 InteRNA Technologies
8.6 Isis Pharmaceuticals
8.7 RXi Pharmaceuticals
8.8 Santaris Pharma
8.9 Silence Therapeutics
8.10 Tekmira Pharmaceuticals Corporation

Figure 4-1: Global RNAi Therapy Market (US$ Billion), 2012-2018
Figure 4-2: RNAi Therapy Market by Region, 2013
Figure 4-3: Global RNAi Drug Clinical Pipeline by Phase (%), 2014
Figure 4-4: Global RNAi Drug Clinical Pipeline by Phase (Number of Drugs), 2014
Figure 4-5: Suspended & Discontinued RNAi Drug in Clinical Pipeline (%), 2014
Figure 4-6: Suspended & Discontinued RNAi Drug in Clinical Pipeline (Number of Drugs), 2014
Figure 4-7: Discontinued RNAi Drug Clinical Pipeline by Phase (%), 2014
Figure 4-8: Discontinued RNAi Drug Clinical Pipeline by Phase (Number of Drugs), 2014
Figure 4-9: Suspended RNAi Drug Clinical Pipeline by Phase (%), 2014
Figure 4-10: Suspended RNAi Drug Clinical Pipeline by Phase (Number of Drugs), 2014

List of Tables

Table 8-1: Arrowhead Research Corporation RNAi Pipeline
Table 8-2: Alnylam Pharmaceuticals RNAi Pipeline
Table 8-3: Benitec Biopharma RNAi Pipeline
Table 8-4: Dicerna Pharmaceuticals RNAi Pipeline
Table 8-5: InteRNA Technologies RNAi Pipeline
Table 8-6: Isis Pharmaceuticals RNAi Pipeline
Table 8-7: RXi Pharmaceuticals Corporation RNAi Pipeline
Table 8-8: Santaris Pharma RNAi Pipeline
Table 8-9: Silence Therapeutics RNAi Pipeline
Table 8-10: Tekmira Pharmaceuticals RNAi Pipeline

Following Information For Each RNAi Drug Profile in Covered in More than 200 Tables in Report:
• Active Indication
• Phase of Development
• Country/Region for Clinical Trial
• Owner / Originator/ Licensee/Collaborator
• Technology Provider
• Chemical/Biological Class
• Administrative Route
• Drug Class


【レポート販売概要】

■ タイトル:世界におけるRNA干渉(RNAi)治療市場動向2018
■ 英文:Global RNA Interference (RNAi) Therapy Market Outlook 2018
■ 発行日:2014年3月
■ 調査会社:Kuick Research
■ 商品コード:KUK4041736
■ 調査対象地域:世界
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。